Clinical Trial Update: Exenatide Once Weekly for Smoking Cessation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on exenatide weekly for smoking cessation across Phase 1 and Phase 2 have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Smoking Cessation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-28